Share this article
Share this article
SANDUSKY, Ohio, April 8, 2021 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
PAOG is working with Veristat, a contract research organization (CRO), dedicated to the clinical advance of therapies and treatments through regulatory approval. PAOG anticipates soon announcing new breakthroughs in its CBD RespRx pharmaceutical research.
PAO Group, Inc.: PAOG Advances CBD Pharmaceutical Developments Backed By US Patent
Sandusky, Ohio (Newsfile Corp. - April 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
PAOG is working with
PAO Group, Inc : PAOG Targets September 2021 to Introduce CBD Nutraceuticals to Market Co-Packed by ALKM and Marketed Through USMJ finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
PURA and PAOG Expand Cannabis Partnership
News provided by
Share this article
Share this article
DALLAS, March 11, 2021 /PRNewswire/ Puration, Inc. (USOTC: PURA) and PAOG Group, Inc. (USOTC: PAOG) today confirmed the two companies continue to work together on developing a variety of cannabis centric applications through a partnership that initiated when PAOG acquired PURA s cannabis cultivation business last year.
The PURA and PAOG partnership includes a pending distribution of PAOG stock to PURA shareholders. PURA shareholders are intended to receive one share of PAOG for every PURA share they hold. The intended distribution has been submitted for review by FINRA. Once the review process is complete, PURA and PAOG plan to promptly proceed with the intended distribution.
PAO Group, Inc : PAOG Announces Save The Date For CBD Nutraceuticals Expansion Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.